← back to search

Werner Hilgers

Institut Sainte Catherine ·
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments, and Lung Cancer Research Studies.
h-index
23
citations
5,401
works
78
NIH funding
primary concept
Medicine
email

Recent publications

Basal/squamous and mixed subtype bladder cancers present poor outcomes after neoadjuvant chemotherapy in the VESPER trial
Annals of Oncology 2024cited by 28position: middledoi
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1
Annals of Oncology 2023cited by 67position: middledoi
Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical data
Cancer Treatment Reviews 2021cited by 37position: middledoi
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
The Lancet 2019cited by 2,157position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2021–2021)Carolina Saldana · Assistance Publique – Hôpitaux de Paris1 papers (2021–2021)Delphine Borchiellini · Observatoire de la Côte d’Azur1 papers (2021–2021)Friederike Schlürmann-Constans · Centre Hospitalier Régional Universitaire de Brest1 papers (2021–2021)Sylvie Négrier · Université Claude Bernard Lyon 11 papers (2021–2021)Isabelle Desmoulins · Laboratoire Jean Perrin1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Christine Chevreau · Institut universitaire du cancer de Toulouse Oncopole1 papers (2021–2021)